a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with IMNM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then IMNM could also see price increases.
Ticker / NAME | Correlation To ATXS | 1D Price Change % | ||
---|---|---|---|---|
ATXS | 100% | -4.93% | ||
IMNM - ATXS | 40% Loosely correlated | -7.21% | ||
INZY - ATXS | 40% Loosely correlated | -5.59% | ||
KALV - ATXS | 40% Loosely correlated | -2.06% | ||
SNDX - ATXS | 40% Loosely correlated | +2.59% | ||
ARVN - ATXS | 39% Loosely correlated | -3.69% | ||
More |
Ticker / NAME | Correlation To ATXS | 1D Price Change % |
---|---|---|
ATXS | 100% | -4.93% |
treatment theme (56 stocks) | 47% Loosely correlated | -1.12% |
drugs theme (254 stocks) | 46% Loosely correlated | -1.72% |
biotechnology theme (238 stocks) | 34% Loosely correlated | -1.80% |
metabolic theme (5 stocks) | 33% Poorly correlated | -1.40% |
cardiovascular theme (11 stocks) | 31% Poorly correlated | -0.69% |
More |